Kuwait – US Pfizer intends to request a license for its...

Kuwait – US Pfizer intends to request a license for its...
Kuwait – US Pfizer intends to request a license for its...
(MENAFN – Al-Anbaa) The US pharmaceutical giant Pfizer expected to apply for a license for the emergency use of its COVID-19 vaccine in late November, about two weeks after the US presidential elections scheduled for the third of the same month.

The company hoped to proceed with the launch of the vaccine after the availability of safety data in the third week of November.

Pfizer President and CEO Albert Burla said in an open letter, “To be clear, if we assume that the data is positive, Pfizer will soon apply for a license for emergency use in the United States after achieving the (verification) phase of safety in the third week of November.” /Nov”.

This announcement means that the United States may have two ready-made vaccines by the end of the year, with Moderna, Massachusetts, to apply on November 25 to obtain a license for its vaccine.

The US Food and Drug Administration (FDA), which licenses pharmaceutical companies to distribute their products in the United States, has asked vaccine developers to monitor if there are side effects after giving volunteers for trials a second dose.

The Food and Drug Administration wants the vaccine to prove efficacy and safety, while Pfizer has to demonstrate its ability to produce vaccine doses in large quantities.

US government-funded Pfizer and Moderna launched the third phase of their clinical trials at the end of July and began producing the shots.

The two companies are seeking to be ready to deliver tens of millions of doses to Americans by the end of the year.

Burla said that Pfizer’s trial, in which 30,000 participants took part, could yield results regarding the effectiveness of the vaccine over the next two weeks.

He added, “I said previously that we are working with the speed of science, and this means that we may know whether our vaccine is effective or not by the end of October.”

Shares in Pfizer, which is researching in partnership with the German company, “Biontech”, rose more than 2% in online trading before the opening of the US market.

MENAFN1710202001300000ID1100974330

These were the details of the news Kuwait – US Pfizer intends to request a license for its... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT US Fed holds key rate steady for fourth straight meeting